Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Am J Trop Med Hyg ; 96(5): 1248-1252, 2017 05.
Artigo em Inglês | MEDLINE | ID: mdl-28500804

RESUMO

From September 2013 to July 2014, several gold miners working in the tropical forest consulted the Maripasoula Health Center in French Guiana for edema and findings consistent with right-sided cardiac failure. Of the 42 cases of beriberi that were diagnosed, one patient died. The laboratory and clinical investigation demonstrated vitamin B1 deficiency in most of the patients tested. Furthermore, 30 of 42 patients responded favorably to 500 mg of intravenous or intramuscular thiamine supplementation. In addition, dietary investigation showed insufficient thiamine intake in these patients. We concluded that patients had acquired beriberi because of diet restrictions, hard labor, and infectious diseases, notably malaria. In 2016, cases were still being reported. We recommend screening for compatible symptoms in gold miners, thiamine supplementation, and nutritional intervention.


Assuntos
Beriberi/dietoterapia , Beriberi/epidemiologia , Surtos de Doenças , Malária/epidemiologia , Mineradores , Tiamina/administração & dosagem , Adulto , Idoso , Beriberi/complicações , Beriberi/fisiopatologia , Comportamento Criminoso , Feminino , Guiana Francesa/epidemiologia , Ouro , Humanos , Malária/complicações , Malária/tratamento farmacológico , Malária/parasitologia , Masculino , Desnutrição/fisiopatologia , Pessoa de Meia-Idade , Estudos Retrospectivos
2.
Malar J ; 12: 367, 2013 Oct 24.
Artigo em Inglês | MEDLINE | ID: mdl-24156660

RESUMO

Malaria is a public health problem in French Guiana. Plasmodium vivax is the most frequent parasite. The objective of this analysis was to estimate the proportion of relapses in the burden of vivax malaria using the statistical rule stating that any case of vivax malaria occurring less than 90 days following a first episode is a relapse.A total of 622 subjects were followed for 2,9 years with 336 first single episodes of P. vivax malaria, and a total of 1,226 episodes of vivax malaria among which 559 were relapses (45.5%). For 194 patients having had falciparum malaria followed by vivax malaria it was estimated that 19% of the vivax episodes occurred less than 90 days following the falciparum episode and thus were possibly relapses due to the activation of latent hypnozoites. Despite the number of vivax cases and the number of relapses, there were only 28 recorded primaquine prescriptions (3.4% of vivax episodes, 4.5% of subjects).The present study points out that despite the fact that nearly half of the P. vivax cases, many of which in children, are caused by latent hypnozoites, only a minority of them benefit from primaquine radical cure. The obstacles to this are discussed and suggestions are made to reduce the burden of vivax malaria in Camopi and other remote health centres in French Guiana.


Assuntos
Malária Vivax/epidemiologia , Plasmodium vivax/isolamento & purificação , Antimaláricos/uso terapêutico , Criança , Pré-Escolar , Estudos de Coortes , Prescrições de Medicamentos/estatística & dados numéricos , Feminino , Seguimentos , Guiana Francesa/epidemiologia , Humanos , Indígenas Sul-Americanos , Lactente , Recém-Nascido , Malária Vivax/tratamento farmacológico , Masculino , Primaquina/uso terapêutico , Recidiva , Estudos Retrospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA